Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 23 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023.
Under the programme initiated 10 August 2023, Novo Nordisk will repurchase B shares for an amount up to DKK 5.7 billion in the period from 10 August 2023 to 31 October 2023.
Since the announcement 16 October 2023, the following transactions have been made:
|Number of B shares (of DKK 0.10)||Average purchase price||Transaction value, DKK|
|Accumulated, last announcement||6,993,162||4,548,993,033|
|16 October 2023||145,000||720.34||104,449,422|
|17 October 2023||145,000||717.25||104,000,773|
|18 October 2023||135,000||711.82||96,095,956|
|19 October 2023||140,000||703.40||98,475,655|
|20 October 2023||145,000||687.35||99,665,731|
|Accumulated under the programme||7,703,162||5,051,680,570|
The details for each transaction made under the share repurchase programme are published on novonordisk.com.
With the transactions stated above, Novo Nordisk owns a total of 40,196,846 B shares of DKK 0.10 as treasury shares, corresponding to 0.9% of the share capital. The total amount of A and B shares of DKK 0.10 in the company is 4,510,000,000 including treasury shares.
Novo Nordisk expects to repurchase B shares for an amount up to DKK 30 billion during a 12-month period beginning 1 February 2023. As of 20 October 2023, Novo Nordisk has since 1 February 2023 repurchased a total of 36,140,324 B shares of DKK 0.10 at an average share price of DKK 562.83 per B share of DKK 0.10 equal to a transaction value of DKK 20,340,911,156.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 59,000 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com,Facebook, Instagram, X, LinkedIn andYouTube.
Contacts for further information
|Ambre James-Brown |
+45 3079 9289
|Elizabeth DeLuca (US)|
+1 609 580 9868
|Daniel Muusmann Bohsen|
+45 3075 2175
|Jacob Martin Wiborg Rode|
+45 3075 5956
|David Heiberg Landsted|
+45 3077 6915
|Mark Joseph Root (US)|
+1 848 213 3219
|Sina Meyer |
+45 3075 6656 firstname.lastname@example.org
|Frederik Taylor Pitter |
+45 3075 8259 email@example.com
Company Announcement No 66 / 2023
AttachmentsTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
TGS Shareholders Approve the Merger Plan with PGS1.12.2023 17:09:37 CET | Press release
OSLO, Norway (1 December 2023) - Reference is made to the joint stock exchange announcement on 18 September 2023 by TGS ASA ("TGS" or the "Company," OSE: TGS) and PGS ASA ("PGS," OSE: PGS) regarding the combination of the two companies (the "Merger") to establish the premier energy data company, as well as subsequent announcements on 25 and 30 October 2023 regarding, respectively, the execution of the definitive merger agreement and notices for extraordinary general meetings for approval. An extraordinary general meeting in TGS was held today at 16:00 hours (Oslo time) as a virtual meeting. All proposals on the agenda were approved with requisite majorities, including the merger plan dated 25 October 2023 and the corresponding share capital increase in the Company. As separately announced by PGS earlier today, the merger has also been approved by the extraordinary general meeting in PGS. As a consequence, the decision to approve the merger will now be filed with the Norwegian Register
Festi hf.: Buyback program week 48 – end of buyback1.12.2023 16:58:38 CET | Press release
In week 48 2023, Festi purchased in total 19,260 own shares for total amount of 3,409,020 ISK as follows: WeekDateTimePurchased shareSahre pricePurchase price 48 29.nov 11:51:24 19.260 177 3.409.020 19.2603.409.020 The execution of the buyback program is in accordance with the Act on Public Limited Companies No 2/1995, Article 5 of the Regulation of the European parliament and of the Council No. 596/2014, on market abuse, the Commissions Delegated Regulation No. 2016/1052 and the Act on Actions against Market Fraud No. 60/2021. Before the purchase Festi held 3,226,966 own shares or 1.06% of issued shares. Festi has now bought in total 3,246,226 own shares (1.07% of issued shares) for 599,999,945 ISK and has finished the buyback. This announcement of purchase of own shares is in accordance with the buyback program announced 21 July 2023 to Nasdaq OMX Iceland. The program envisages the buyback of a total of 3,500,000 own shares or 1.15% of the issued shares, with the cap of 600 million I
Fastsættelse af rentetrigger for rentetilpasningsobligationer1.12.2023 16:35:59 CET | pressemeddelelse
Fastsættelse af rentetrigger for rentetilpasningsobligationer DLR har afsluttet obligationssalget i forbindelse med refinansieringen af rentetilpasningslån med årlig rentetilpasning pr. 2. januar 2024 og har fastsat niveauet for rentetriggeren på de 1-årige rentetilpasningsobligationer i DKK, der kan udløse forlængelse af løbetiden ved næste års refinansiering. Flere oplysninger om rentetriggere kan ses på www.dlr.dk/investor. Oplysninger om obligationssalget i forbindelse med refinansieringerne kan ses samme sted. Spørgsmål vedrørende rentetrigger kan rettes til Fondschef Nikolaj Knudsen på telefon 33 42 07 38. Med venlig hilsen DLR Kredit A/S Vedhæftet fil Fastsættelse af rentetrigger 2023-12-01
Hydro completes sale to Glencore1.12.2023 16:30:00 CET | Press release
Hydro has completed the USD 1.11 billion transaction for the sale of 30 percent interest in the Brazilian alumina refinery Hydro Alunorte and Hydro’s 5 percent interest in the bauxite producer Mineracão Rio do Norte (MRN), together with Vale’s 40 percent stake in MRN. “We are looking forward to work with Glencore to further develop Alunorte. Glencore has broad industrial experience within metals and mining, which adds to the significant progress our bauxite and alumina area has made to bring down the footprint of alumina production. This enables Hydro to strengthen our position in low-carbon aluminium,” says President and CEO, Hilde Merete Aasheim. Hydro and Glencore will continue efforts to reduce carbon emissions from Alunorte through the fuel switch project that aims to substitute fuel oil with LNG, and the electrification of boilers. This will bring Alunorte to the first decile on the global carbon curve already in 2025, positioning Alunorte as a leading supplier of low-carbon alum
Hydro fullfører salget til Glencore1.12.2023 16:30:00 CET | Pressemelding
Hydro har fullført transaksjonen på 1,11 milliarder USD for salg av 30 prosent eierandel i det brasilianske aluminaraffineriet Hydro Alunorte og Hydros eierandel på 5 prosent i bauksittprodusenten Mineracão Rio do Norte (MRN), samt Vales eierandel på 40 prosent i MRN. – Vi ser frem til å samarbeide med Glencore for å videreutvikle Alunorte. Glencore har bred industriell erfaring innen metaller og gruvedrift, noe som forsterker den betydelige fremgangen forretningsområdet vårt for bauksitt og alumina vårt har gjort for å redusere fotavtrykket fra aluminaproduksjonen. Dette gjør Hydro i stand til å styrke vår posisjon innen lavkarbonaluminium, sier konsernsjef Hilde Merete Aasheim. Hydro og Glencore vil fortsette arbeidet med å redusere karbonutslippene fra Alunorte gjennom drivstoffbytteprosjektet som har som mål å erstatte tungolje med LNG, og elektrifisering av fyrkjeler. Dette vil bringe Alunorte til den første desilen på den globale karbonkurven allerede i 2025, og posisjonere Aluno